Sign in
Taking people in United StatesNo phase

Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation

Key facts

Who runs it
Penn State University
Where
Boston and State College, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
1,050 people, planned
Started
3 Apr 2024
Expected to end
May 2028
Type of study
Interventional, 2 groups
Treatments tested
  • READI-SET GO UB-CAM delirium screening into EHR
Record updated
20 February 2026

Who can take part

Age
70 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • General medicine (hospitalist) service
  • Age 70 or older
  • Expected hospital length of stay of 3 or more days

Who cannot take part

  • Inability to communicate adequately in English
  • Admitted for terminal care

Where in United States

  • Beth Israel Deaconness Medical CenterBoston, United StatesContact: Edward Marcantonio, MDTaking people
  • Mount Nittany Medical CenterState College, United StatesContact: Donna Fick, PhDTaking people

About the trial

What the trial wants to find out

The goal of this step-wedge trial is to test the implementation of daily nurse screening for delirium in routine care and its impact on outcomes and complications in hospitalized older adults admitted to 6 general medicine/surgery units at 3 hospitals in Pennsylvania and Massachusetts.

Read full original descriptionShow less

The main question[s] it aims to answer are:

* 1. To test the fidelity, accuracy, and durability of implementing daily nurse screening for delirium using the UB-CAM in routine care. * 2. To evaluate the impact of UB-CAM delirium screening on patient and care partner centered outcomes assessed at one month follow-up interviews 3. To evaluate the impact of UB-CAM screening on rates of delirium complications (falls, pressure injury, aspiration) and adverse delirium management (psychoactive medication use, restraint use).

Participants (patients) will be assessed for delirium on study days 1, 2 and 3 (or until hospital discharge) and will be asked basic demographics. These patients will be contacted by phone 1 month after enrollment to collect information about inpatient facility use and to administer the Delirium Burden Patient Scale.

Participants (care partners) will be interviewed at the patient's discharge to complete the Alzheimer's Disease-8 scale. These care partners will be contacted by phone 1 month after enrollment to complete the Delirium Burden Caregiver Scale and to complete a Qualitative Interview which includes questions about communication and collaboration.

The 2 groups in the trial

  • Readi Set Go Patient Oriented SampleTreatment being tested

    Hospitalized older adults at risk of developing delirium providing informed consent will have the UB-CAM integrated into the electronic health record and RSDA delirium assessments.

    Treatment: READI-SET GO UB-CAM delirium screening into EHR

  • Readi Set Go Administrative SampleTreatment being tested

    All patient admitted to the study wards for the duration of the study will have the UB-CAM integrated into the electronic health record

    Treatment: READI-SET GO UB-CAM delirium screening into EHR

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
READI-SET-GO:Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation to Create Gero Friendly Organizations
Record updated
20 February 2026